QNCX (Quince Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Quince Therapeutics, Inc. Common Stock (QNCX) is a publicly traded Healthcare sector company. As of May 21, 2026, QNCX trades at $1.04 with a market cap of $16.22M and a P/E ratio of -0.64. QNCX moved +0.00% today. Year to date, QNCX is -96.22%; over the trailing twelve months it is -89.41%. Its 52-week range spans $0.79 to $45.50. Rallies surfaces QNCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns QNCX stock?

Hedge funds tracked by Rallies that own QNCX include Renaissance Technologies, Two Sigma, Two Sigma, and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Quince Therapeutics, Inc. Common Stock.

QNCX Key Metrics

Key financial metrics for QNCX
MetricValue
Price$1.04
Market Cap$16.22M
P/E Ratio-0.64
EPS$-1.68
Dividend Yield0.00%
52-Week High$45.50
52-Week Low$0.79
Volume97.21K
Avg Volume0
Revenue (TTM)$0
Net Income$-80.77M
Gross Margin0.00%

Top Hedge Funds Holding QNCX

  • Renaissance Technologies holds 523.05K shares of QNCX, changed +0.09% as of Dec 31, 2024.
  • Two Sigma holds 93.60K shares of QNCX, changed -3.60% as of Jun 30, 2024.
  • Two Sigma holds 30.34K shares of QNCX, changed +130.14% as of Dec 31, 2024.
  • Citadel Advisors holds 4.00K shares of QNCX, changed -96.26% as of Dec 31, 2024.

Latest QNCX News

Recent QNCX Insider Trades

  • Benatti Luca sold 50.00K (~$173.50K) on Dec 26, 2025.
  • Thye Dirk bought 77.00K (~$53.90K) on Aug 30, 2024.
  • Thye Dirk bought 77.50K (~$53.47K) on Aug 29, 2024.

QNCX Analyst Consensus

QNCX analyst coverage data. Average price target: $0.00.

Common questions about QNCX

Who owns QNCX stock?
Hedge funds tracked by Rallies that own QNCX include Renaissance Technologies, Two Sigma, Two Sigma, and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Quince Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for QNCX?
Yes. Rallies tracks hedge fund and 13F ownership data for QNCX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is QNCX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for QNCX. It does not provide personalized investment advice.
QNCX

QNCX